Researcher patents 'roach motel' for cancer

by Louisa Kellie,University of Texas at ArlingtonA cancer trap. Credit: UTAThe University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts an

Updated on: June 04,2024

Researcher patents 'roach motel' for cancer

by Louisa Kellie,University of Texas at ArlingtonA cancer trap. Credit: UTAThe University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts an

Updated on:June 04,2024

New study reveals anti-cancer properties in Kencur ginger

byOsaka Metropolitan UniversityJamu – an Indonesian drink prepared from Kencur ginger. Credit: Akiko Kojima, Osaka Metropolitan UniversityYou may know it as an aromatic spice to add flavor to yo

Updated on: January 13,2024

New study reveals anti-cancer properties in Kencur ginger

byOsaka Metropolitan UniversityJamu – an Indonesian drink prepared from Kencur ginger. Credit: Akiko Kojima, Osaka Metropolitan UniversityYou may know it as an aromatic spice to add flavor to yo

Updated on:January 13,2024

Genetic ancestry and social environment may influence how aggressive breast cancer is in Black women

by Rutgers Cancer Institute of New JerseyKaplan-Meier Survival Curves for All-Cause Mortality by Quartiles (Q) of African Ancestry and Neighborhood Socioeconomic Status (nSES) in 1,575 Black Women wit

Updated on: May 13,2024

Genetic ancestry and social environment may influence how aggressive breast cancer is in Black women

by Rutgers Cancer Institute of New JerseyKaplan-Meier Survival Curves for All-Cause Mortality by Quartiles (Q) of African Ancestry and Neighborhood Socioeconomic Status (nSES) in 1,575 Black Women wit

Updated on:May 13,2024

Levonorgestrel IUD feasible for low-risk, early uterine cancer

(HealthDay)—A levonorgestrel-releasing intrauterine device (LNG-IUD) is effective in the majority of patients undergoing conservative treatment for low-risk endometrial cancer and complex atypical hyp

Updated on: March 24,2024

Levonorgestrel IUD feasible for low-risk, early uterine cancer

(HealthDay)—A levonorgestrel-releasing intrauterine device (LNG-IUD) is effective in the majority of patients undergoing conservative treatment for low-risk endometrial cancer and complex atypical hyp

Updated on:March 24,2024

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren

Updated on: January 30,2024

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren

Updated on:January 30,2024

Researchers discover crucial step in creating blood stem cells

by Iowa State UniversityBlood stem cells show forming in the trunk of a zebrafish embryo. The blood stem cells are yellow, with the red tubes are the aorta on the top and a vein on the bottom. Cr

Updated on: February 03,2024

Researchers discover crucial step in creating blood stem cells

by Iowa State UniversityBlood stem cells show forming in the trunk of a zebrafish embryo. The blood stem cells are yellow, with the red tubes are the aorta on the top and a vein on the bottom. Cr

Updated on:February 03,2024

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Updated on: January 23,2024

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Updated on:January 23,2024

In high-risk neuroblastoma, two stem cell transplants may be better than one

by Nancy Fliesler,Children's Hospital BostonCredit: Children's Hospital BostonSince the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of

Updated on: March 09,2024

In high-risk neuroblastoma, two stem cell transplants may be better than one

by Nancy Fliesler,Children's Hospital BostonCredit: Children's Hospital BostonSince the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of

Updated on:March 09,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on: January 23,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on:January 23,2024

New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

by Society of Nuclear Medicine and Molecular ImagingGraphical abstract. Credit:Journal of Nuclear Medicine(2022). DOI: 10.2967/jnumed.121.263177A novel PET radiotracer can accurately asses

Updated on: January 11,2024

New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

by Society of Nuclear Medicine and Molecular ImagingGraphical abstract. Credit:Journal of Nuclear Medicine(2022). DOI: 10.2967/jnumed.121.263177A novel PET radiotracer can accurately asses

Updated on:January 11,2024

Researchers publish consensus statement on patient selection and appropriate use of Lu-177 PSMA-617 radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingProstate cancer cells. Credit: NIH Image GalleryThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement t

Updated on: February 20,2024

Researchers publish consensus statement on patient selection and appropriate use of Lu-177 PSMA-617 radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingProstate cancer cells. Credit: NIH Image GalleryThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement t

Updated on:February 20,2024

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on: January 22,2024

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on:January 22,2024